trial

Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder

NCTId NCT06221852
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 50 (estimated)
Sponsored by Mclean Hospital
Primary completion 2027-09-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2024-03-12
Primary completion
2027-09-30
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Ketogenic DietDietary Guidelines for Americans

Sponsors

Mclean HospitalLead Sponsor
Baszucki Family FoundationCollaborator

Investigators

1
Virginie-Anne Chouinard, MDPrincipal Investigator

Sites

1 total
Belmont, United States

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2027-09-30
Status
RECRUITING
relationships
The graph out of here
drug
Ketogenic Diet
drug
Dietary Guidelines for Americans
drug
lead_sponsor
Mclean Hospital
company
collaborator
Baszucki Family Foundation
company
indication
Bipolar Disorder
indication
Insulin Resistance
indication
Schizoaffective Disorder
indication
investigator
Virginie-Anne Chouinard, MD
person